期刊文献+

pEGFP-N3-TFPI-2真核表达载体的构建和鉴定 被引量:1

Construction and Identification of Eukaryotic Expression Vector of pEGFP-N3-TFPI-2
原文传递
导出
摘要 目的构建pEGFP-N3-TFPI-2真核表达载体,为研究TFPI-2基因的功能做准备。方法从胎盘组织中提取总RNA,逆转录合成cDNA,再以PCR法进行扩增。将扩增的TFPI-2基因片段克隆到pEGFP-N3真核表达载体上,经XhoⅠ和KpnⅠ双酶切后,行1%琼脂糖凝胶电泳鉴定,同时测定其DNA序列。将pEGFP-N3-TFPI-2真核表达载体以脂质体LipofectamineTM 2000介导的方法转染Top10感受态细胞(转染组),同时设空白对照组(仅转染pEGFP-N3质粒)和未转染组(不予转染)。采用Western blot法检测3组细胞中TFPI-2蛋白的表达情况。结果总RNA经分光光度法验证,其纯度符合PCR法扩增的要求。构建的pEGFP-N3-TFPI-2真核表达载体经XhoⅠ和KpnⅠ双酶切后,行1%琼脂糖凝胶电泳,结果显示,分别在708 bp处和4 700 bp处有特异扩增条带,大小与理论值一致。DNA序列测定结果证实,pEFFP-N3-TFPI-2真核表达载体的序列完全正确。Western blot法结果显示,TFPI-2蛋白的表达量转染组为0.657 3±0.032 5,空白对照组为0.301 7±0.028 7,未转染组为0.314 3±0.026 6,转染组TFPI-2蛋白的表达量高于空白对照组和未转染组,差异有统计学意义(P<0.01)。结论本实验成功构建了pEGFP-N3-TFPI-2真核表达载体,为TFPI-2基因功能的研究奠定了基础。 Objective To construct eukaryotic expression vector ofpEGFP-N3-TFPI-2, and to provide the base of studying the function of TFPI-2 gene. Methods Extraction of total RNA from placental tissue was extracted at first, and then reverse transcriptase synthesis of eDNA was carried out. The eDNA fragment ofTFPI-2 gene which was obtained by real time PCR (RT-PCID was inserted into eukaryotic expression vector ofpEGFP-N3. After double digestion with Xho I and Kpn I , the recombinant vector of pEGFP-N3-TFPI-2 was identified in 1% agarose gel eleetrophoresis and was tested by the sequence analysis. Then, the recombinant vector of pEGFP-N3-TFPI-2 (transfection group) and vector of pEGFP-N3 (blank control group) were transfected into Topl0 competent cells with LipofectamineTM 2000, but no transfeetion-related treatment was performed in cells of untransfection group. Western blot method was used to test the expression of TFPI-2 protein in cells of 3 groups. Results The purity of total RNA which were analysis by agarose gel electrophoresis and spectrophotometry were fit for PCR. After coding of TFPI-2 gene fragment and eukaryotic expression vector of pEGFP-N3, the recombinant plasmid of pEGFP-N3-TFPI-2 were got double digestion with Xho I and Kpn I , and was identified in 1% agarose gel electrophoresis, of which showing that there were 2 specific amplification of strips at 708 bp and 4 700 bp. Result of sequence analysis confirmed that the size of recombinant vector was consistent with the theoretical value. Results of Western blot showed that the expression of TFPI-2 protein in transfection group (0. 657 3 ± 0. 032 5) was higher than those of blank control group (0. 301 7 ± 0. 028 7) and untransfection group (0. 314 3 ± 0. 026 6), P〈 0. 01. Conclusions The eukaryotic expression vector of pEGFP-N3-TFPI-2 has been constructed successfully, which laiding the founda-tion for the analysis about function of TFPI-2 gene.
出处 《中国普外基础与临床杂志》 CAS 2014年第3期300-304,共5页 Chinese Journal of Bases and Clinics In General Surgery
关键词 组织因子途径抑制物-2 pEGFP-N3真核载体 双酶切反应 序列分析 Western BLOT法 Tissue factor pathway inhibitor-2 Eukaryotic expression vector of pEGFP-N3 Double digestion Sequence analysis Western blot method
  • 相关文献

参考文献25

  • 1王蒙,汤志刚.TFPI-2的生物学作用及其与肿瘤的关系[J].安徽医药,2012,16(7):1016-1017. 被引量:4
  • 2Xu C, Wang H, He H, et al. Low expression of TFPI-2 associated with poor survival outcome in patients with breast cancer [ J 1. BMC Cancer, 2013, 13: 118.
  • 3Kim Y, Stolarska MA, Othmer HG. The role of the microenvi- ronment in tumor growth and invasion IJl. Prog Biophys Mol Biol, 2011. 106(2): 353-379.
  • 4. Wong CM, Ng YL, Lee JM, et al. Tissue factor pathway in-hibi- tor-2 as a frequently silenced tumor suppressor gene in hepa-toce- llularcarcinoma [Jl. Hepatology, 2007, 45(5): 1129-1138.
  • 5George J, Gondi CS, Dinh DH, et al. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers caspase-mediated pathway and apoptosis [ J 1- Clin Cancer Res, 2007, 13(12): 3507-3517.
  • 6Takada H, Wakabayashi N, Dohi O, et al. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer [ J ]. Cancer Genet Cytogenet, 2010, 197(1): 16-24.
  • 7Gl6ckner SC, Dhir M, Yi JM, et al. Methylation of TFPI2 in stool DNA : a potential novel biomarker for the detection of colo- rectal cancer [ J ]. Cancer Res, 2009, 69(11 ): 4691-4699.
  • 8Tsunoda S, Smith E, De Young NJ, et al. Methylation ofCLDN6, FBN2, RBPI, RBP4, TFPI2, and TMEFF2 in esophageal squa- mous cell carcinoma [J]. Oncol Rep, 2009, 21(4): 1067-1073.
  • 9Watanabe A, Hoshino D, Hosino D, et al. Critical role of tran- sient activity of MT1-MMP for ECM degradation in invadopodia [J]. PLoS Comput Biol. 2013, 9(5): e1003086.
  • 10Taniwaki K, Fukamachi H, Komori K, et al. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type l-MMP-dependent tumor growth in mice [J ]. Cancer Res, 2007, 67(9): 4311-4319.

二级参考文献48

  • 1仲任,黄瑞滨,宋善俊.Role of Tissue Factor Pathway Inhibitor-2 in Ovarian Tumor Migration and Invasion[J].The Chinese-German Journal of Clinical Oncology,2005,4(1):53-55. 被引量:2
  • 2GEORGE J, GONDI CS, DINH DH, et al. Restoration of tissue factor pathway inhibitor-2 in a human glioblastoma cell line triggers easpase-mediated pathway and apoptosis [J]. Clin Cancer Res, 2007, 13(12): 3507-3517.
  • 3WONG CM, NG YL, LEE JM, et al.Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma[J]. Hepatology, 2007, 45(5): 1129-1138.
  • 4NOBEYAMA Y, OKOCHI-TAKADA E, FURUTA J, et al.Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas[J]. Int J Cancer, 2007, 121(2): 301-307.
  • 5KONDRAGANTI S, GONDI CS, GUJRATI M, et al.Restoration of tissue factor pathway inhibitor inhibits invasion and tumor growth in vitro and in vivo in a malignant meningioma cell line[J]. Int J Oncol, 2006, 29(1): 25-32.
  • 6YANAMANDRA N, KONDRAGANTI S, GONDI CS, et al.Recombinant adeno-associated virus (rAAV) expressing TFPI-2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line[J]. Int J Cancer, 2005, 115(6): 998-1005.
  • 7ROLLIN J, IOCHMANN S, BLECHET C, et al. Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer [J]. Br J Cancer, 2005, 92 (4): 775-783.
  • 8XU Z, MAITI D, KISIEL W, et al. Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells [J]. Arterioscler Thromb Vasc Biol, 2006, 26(12): 2819-2825.
  • 9KEMPAIAH P, KISIEL W. Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line[J]. Apoptosis, 2008, 13(5): 702-715.
  • 10Sierko E,Wojtukiewicz M Z,Kisiel W.The role of tissue factor pathway inhibitor-2 in cancer biology[J].Semin Thromb Hemost,2007,33(7):653-659.

共引文献9

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部